Showing results (141-150 of 5,666) with videos related to

Sort By:
Pageof 567
The Oncologist|May 25, 2006
Benign breast diseases: classification, diagnosis, and managementMerih Guray, Aysegul A Sahin
The Oncologist|May 25, 2006
Lung cancer screeningApar Kishor Ganti, James L Mulshine
The Oncologist|May 25, 2006
Ewing's sarcoma family of tumors: current managementMark Bernstein, Heinrich Kovar, Michael Paulussen, et al.
The Oncologist|June 2, 2020
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III TrialLee S Schwartzberg, Gajanan Bhat, Julio Peguero, et al.
The Oncologist|May 6, 2021
Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon CancerLi-Chun Chang, Chia-Tung Shun, Been-Ren Lin, et al.
The Oncologist|May 6, 2021
Opportunities for Improvement in the Administration of Neoadjuvant Chemotherapy for T4 Breast Cancer: A Comparison of the U.S. and NigeriaAnya Romanoff, Olalekan Olasehinde, Debra A Goldman, et al.
The Oncologist|May 6, 2021
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3Hiroji Iwata, Yoshiko Umeyama, Yuan Liu, et al.
The Oncologist|April 29, 2021
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with AbemaciclibSarah Badaoui, Ganessan Kichenadasse, Andrew Rowland, et al.
The Oncologist|May 18, 2021
Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE)Shukui Qin, Jiafu Ji, Rui-Hua Xu, et al.
The Oncologist|May 21, 2021
Humoral Immune Response of SARS-CoV-2-Infected Patients with Cancer: Influencing Factors and MechanismsMiguel Esperança-Martins, Lisa Gonçalves, Inês Soares-Pinho, et al.
Pageof 567